State Street’s Arbutus Biopharma ABUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $28.5M | Buy |
6,342,510
+434,299
| +7% | +$1.9M | ﹤0.01% | 2046 |
|
|
2025
Q4 | $28.4M | Buy |
5,908,211
+1,809,893
| +44% | +$8.14M | ﹤0.01% | 2059 |
|
|
2025
Q3 | $18.6M | Sell |
4,098,318
-361,444
| -8% | -$1.33M | ﹤0.01% | 2294 |
|
|
2025
Q2 | $13.8M | Buy |
4,459,762
+96,255
| +2% | +$320K | ﹤0.01% | 2397 |
|
|
2025
Q1 | $15.2M | Sell |
4,363,507
-663,122
| -13% | -$2.21M | ﹤0.01% | 2278 |
|
|
2024
Q4 | $16.4M | Buy |
5,026,629
+619,496
| +14% | +$2.28M | ﹤0.01% | 2328 |
|
|
2024
Q3 | $17M | Buy |
4,407,133
+1,472,652
| +50% | +$5.65M | ﹤0.01% | 2312 |
|
|
2024
Q2 | $9.07M | Buy |
2,934,481
+322,591
| +12% | +$968K | ﹤0.01% | 2618 |
|
|
2024
Q1 | $6.74M | Buy |
2,611,890
+215,130
| +9% | +$557K | ﹤0.01% | 2799 |
|
|
2023
Q4 | $5.99M | Buy |
2,396,760
+235,359
| +11% | +$461K | ﹤0.01% | 2862 |
|
|
2023
Q3 | $4.39M | Sell |
2,161,401
-47,898
| -2% | -$100K | ﹤0.01% | 2981 |
|
|
2023
Q2 | $5.08M | Buy |
2,209,299
+141,247
| +7% | +$368K | ﹤0.01% | 2989 |
|
|
2023
Q1 | $6.27M | Buy |
2,068,052
+42,986
| +2% | +$121K | ﹤0.01% | 2902 |
|
|
2022
Q4 | $4.72M | Buy |
2,025,066
+13,690
| +0.7% | +$32.7K | ﹤0.01% | 3061 |
|
|
2022
Q3 | $3.84M | Buy |
2,011,376
+52,456
| +3% | +$123K | ﹤0.01% | 3185 |
|
|
2022
Q2 | $5.31M | Buy |
1,958,920
+183,984
| +10% | +$471K | ﹤0.01% | 3073 |
|
|
2022
Q1 | $5.29M | Buy |
1,774,936
+91,107
| +5% | +$279K | ﹤0.01% | 3150 |
|
|
2021
Q4 | $6.55M | Buy |
1,683,829
+27,446
| +2% | +$107K | ﹤0.01% | 3117 |
|
|
2021
Q3 | $7.11M | Buy |
1,656,383
+500,289
| +43% | +$1.67M | ﹤0.01% | 3057 |
|
|
2021
Q2 | $3.5M | Buy |
1,156,094
+1,099,484
| +1,942% | +$3.41M | ﹤0.01% | 3396 |
|
|
2021
Q1 | $189K | Hold |
56,610
| – | – | ﹤0.01% | 3849 |
|
|
2020
Q4 | $201K | Buy |
56,610
+4,700
| +9% | +$16.5K | ﹤0.01% | 3754 |
|
|
2020
Q3 | $162K | Buy |
+51,910
| New | +$158K | ﹤0.01% | 3680 |
|
|
2020
Q2 | – | Sell |
-11,686
| Closed | -$12K | – | 3810 |
|
|
2020
Q1 | $12K | Hold |
11,686
| – | – | ﹤0.01% | 3721 |
|
|
2019
Q4 | $32K | Hold |
11,686
| – | – | ﹤0.01% | 3748 |
|
|
2019
Q3 | $18K | Sell |
11,686
-31,793
| -73% | -$54.8K | ﹤0.01% | 3766 |
|
|
2019
Q2 | $90K | Sell |
43,479
-530,997
| -92% | -$1.36M | ﹤0.01% | 3679 |
|
|
2019
Q1 | $2.06M | Sell |
574,476
-23,456
| -4% | -$90K | ﹤0.01% | 3137 |
|
|
2018
Q4 | $2.29M | Buy |
597,932
+14,718
| +3% | +$72.5K | ﹤0.01% | 3063 |
|
|
2018
Q3 | $5.51M | Buy |
583,214
+84,135
| +17% | +$835K | ﹤0.01% | 2818 |
|
|
2018
Q2 | $3.64M | Buy |
499,079
+485,319
| +3,527% | +$2.89M | ﹤0.01% | 3015 |
|
|
2018
Q1 | $69K | Buy |
13,760
+760
| +6% | +$4.02K | ﹤0.01% | 3641 |
|
|
2017
Q4 | $66K | Sell |
13,000
-281
| -2% | -$1.65K | ﹤0.01% | 3628 |
|
|
2017
Q3 | $83K | Buy |
13,281
+156
| +1% | +$667 | ﹤0.01% | 3645 |
|
|
2017
Q2 | $47K | Buy |
13,125
+315
| +2% | +$1.08K | ﹤0.01% | 3597 |
|
|
2017
Q1 | $41K | Buy |
12,810
+510
| +4% | +$1.42K | ﹤0.01% | 3585 |
|
|
2016
Q4 | $30K | Buy |
12,300
+510
| +4% | +$1.48K | ﹤0.01% | 3587 |
|
|
2016
Q3 | $40K | Sell |
11,790
-679
| -5% | -$2.65K | ﹤0.01% | 3500 |
|
|
2016
Q2 | $43K | Buy |
12,469
+468
| +4% | +$1.98K | ﹤0.01% | 3594 |
|
|
2016
Q1 | $50K | Sell |
12,001
-714
| -6% | -$2.55K | ﹤0.01% | 3615 |
|
|
2015
Q4 | $57K | Sell |
12,715
-21,543
| -63% | -$118K | ﹤0.01% | 3585 |
|
|
2015
Q3 | $208K | Buy |
+34,258
| New | +$304K | ﹤0.01% | 3462 |
|
Other funds holding ABUS
TSC
WCM
VCM
RCMNY
ACM
